Src constitutive activation in human tumours frequently occurs and Src (Fyn and Lyn) have been demonstrated to participate in prostate tumourigenesis.36, 37, 38, 39 Overactive protein signalling cascades have been implicated in several modes of drug resistance including castrate-resistant prostate cancer.40, 41. The gene discussed is LYN; the disease is prostate carcinoma.